Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1–S276 (2021).
Li, A. S., Ingham, J. F. & Lennon, R. Genetic disorders of the glomerular filtration barrier. Clin. J. Am. Soc. Nephrol. 15, 1818–1828 (2020).
Article CAS PubMed PubMed Central Google Scholar
Barker, D. F. et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248, 1224–1227 (1990).
Article CAS PubMed Google Scholar
Kestilä, M. et al. Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome. Mol. Cell 1, 575–582 (1998).
Boute, N. et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24, 349–354 (2000).
Article CAS PubMed Google Scholar
Stark, Z., Byrne, A. B., Sampson, M. G., Lennon, R. & Mallett, A. J. A guide to gene-disease relationships in nephrology. Nat. Rev. Nephrol. 21, 115–126 (2025).
Thomas, C. P. et al. Genetic evaluation of living kidney donor candidates: a review and recommendations for best practices. Am. J. Transpl. 23, 597–607 (2023).
Pollak, M. R., Quaggin, S. E., Hoenig, M. P. & Dworkin, L. D. The glomerulus: the sphere of influence. Clin. J. Am. Soc. Nephrol. 9, 1461–1469 (2014).
Article PubMed PubMed Central Google Scholar
Kopp, J. B. et al. Podocytopathies. Nat. Rev. Dis. Primers 6, 68 (2020).
Article PubMed PubMed Central Google Scholar
Kim, J. M. et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300, 1298–1300 (2003).
Article CAS PubMed Google Scholar
Hinkes, B. et al. Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible. Nat. Genet. 38, 1397–1405 (2006).
Article CAS PubMed Google Scholar
Dryer, S. E. & Reiser, J. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am. J. Physiol. Ren. Physiol. 299, F689–F701 (2010).
Patrakka, J. & Tryggvason, K. Molecular make-up of the glomerular filtration barrier. Biochem. Biophys. Res. Commun. 396, 164–169 (2010).
Article CAS PubMed Google Scholar
Kaplan, J. M. et al. Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24, 251–256 (2000).
Article CAS PubMed Google Scholar
Mele, C. et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N. Engl. J. Med. 365, 295–306 (2011).
Article CAS PubMed PubMed Central Google Scholar
Brown, E. J. et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat. Genet. 42, 72–76 (2010).
Article CAS PubMed Google Scholar
Bierzynska, A. et al. MAGI2 mutations cause congenital nephrotic syndrome. J. Am. Soc. Nephrol. 28, 1614–1621 (2017).
Article CAS PubMed Google Scholar
Ashraf, S. et al. Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. Nat. Commun. 9, 1960 (2018).
Article PubMed PubMed Central Google Scholar
Gupta, I. R. et al. ARHGDIA: a novel gene implicated in nephrotic syndrome. J. Med. Genet. 50, 330–338 (2013).
Article CAS PubMed PubMed Central Google Scholar
Lipska, B. S. et al. Genotype–phenotype associations in WT1 glomerulopathy. Kidney Int. 85, 1169–1178 (2014).
Article CAS PubMed Google Scholar
Vivante, A. et al. Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children. Pediatr. Nephrol. 34, 1607–1613 (2019).
Article PubMed PubMed Central Google Scholar
Boyer, O. et al. LMX1B mutations cause hereditary FSGS without extrarenal involvement. J. Am. Soc. Nephrol. 24, 1216–1222 (2013).
Article CAS PubMed PubMed Central Google Scholar
Braun, D. A. et al. Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome. J. Clin. Invest. 128, 4313–4328 (2018).
Article PubMed PubMed Central Google Scholar
Lovric, S. et al. Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency. J. Clin. Invest. 127, 912–928 (2017).
Article PubMed PubMed Central Google Scholar
Hall, A. M. et al. The urinary proteome and metabonome differ from normal in adults with mitochondrial disease. Kidney Int. 87, 610–622 (2015).
Article CAS PubMed Google Scholar
Parasyri, M. et al. Renal phenotype in mitochondrial diseases: a multicenter study. Kidney Dis. 8, 148–159 (2022).
Bakis, H. et al. Renal involvement is frequent in adults with primary mitochondrial disorders: an observational study. Clin. Kidney J. 16, 100–110 (2023).
Article CAS PubMed Google Scholar
Schijvens, A. M. et al. Mitochondrial disease and the kidney with a special focus on CoQ10 deficiency. Kidney Int. Rep. 5, 2146–2159 (2020).
Article PubMed PubMed Central Google Scholar
Butt, L. et al. A molecular mechanism explaining albuminuria in kidney disease. Nat. Metab. 2, 461–474 (2020).
Article CAS PubMed Google Scholar
Naylor, R. W., Morais, M. R. P. T. & Lennon, R. Complexities of the glomerular basement membrane. Nat. Rev. Nephrol. 17, 112–127 (2021).
Article CAS PubMed Google Scholar
Savige, J., Huang, M., Croos Dabrera, M. S., Shukla, K. & Gibson, J. Genotype-phenotype correlations for pathogenic COL4A3-COL4A5 variants in X-linked, autosomal recessive, and autosomal dominant Alport syndrome. Front. Med. 9, 865034 (2022).
Funk, S. D., Lin, M.-H. & Miner, J. H. Alport syndrome and Pierson syndrome: diseases of the glomerular basement membrane. Matrix Biol. 71–72, 250–261 (2018).
Article PubMed PubMed Central Google Scholar
Has, C. et al. Integrin α3 mutations with kidney, lung, and skin disease. N. Engl. J. Med. 366, 1508–1514 (2012).
Article CAS PubMed Google Scholar
Jayadev, R. et al. A basement membrane discovery pipeline uncovers network complexity, regulators, and human disease associations. Sci. Adv. 8, eabn2265 (2022).
Comments (0)